June 01, 2025 10:45 ET | Source: Allogene Therapeutics, Inc. Data Highlights Transformative Promise of CAR T in Solid TumorsPhase…
SHANGHAI and HONG KONG, May 23, 2025 (GLOBE NEWSWIRE) -- NETCLASS TECHNOLOGY INC. (Nasdaq: NTCL; “the Company” or “NetClass”), a…
KUALA LUMPUR, MALAYSIA, May 15, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"),…
May 14, 2025 22:57 ET | Source: Mesoblast Limited NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB),…
Revenue of $3.4 million in 1Q 2025 Domestication to U.S. Completed Awarded $30 Million Contract for AI-First Constellation and Closed…
SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq-CM: TSBX), a biotechnology company…
New York, USA, May 08, 2025 (GLOBE NEWSWIRE) -- In 2025, as the charm of cryptocurrency is attracting global attention;…
May 08, 2025 07:00 ET | Source: Cullinan Therapeutics, Inc. Company received approval from European Medicines Agency (EMA) for CLN-978;…
On track for six major study readouts across four programs over the next 12 months Ready to initiate pivotal studies…
Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a…
